Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-28 @ 12:11 AM
Study NCT ID:
NCT03713632
Status:
COMPLETED
Last Update Posted:
2024-10-09
First Post:
2018-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-19
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-18
First Submit QC Date:
None
Study First Post Date:
2018-10-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-12
Results First Submit QC Date:
None
Results First Post Date:
2023-08-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-07-16
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-10-09
Last Update Post Date Type:
ACTUAL